Logo of Dallah Healthcare Co.
Dallah Healthcare Co. (DHC) announced that negotiations with the selling shareholders of Dr Mohammad bin Rashed Al Faqih & Partners Co. to purchase all their shares terminated without an agreement.
In a statement to Tadawul, DHC said that the proposed deal will not be completed this time, adding that there is no financial impact from the termination of negotiations.
On Sept. 18, 2022, DHC board of directors decided to start negotiations with shareholders selling their stake of 68.79%, or 34.395 million shares, in Dr Mohammad bin Rashed Al Faqih & Partners Co., Argaam earlier reported.
Comments
{{DisplayName}}
{{ElapsedTime}}